Information Provided By:
Fly News Breaks for April 18, 2019
DERM
Apr 18, 2019 | 14:18 EDT
Cantor Fitzgerald analyst Louise Chen raised her price target on Dermira to $25 as she is now including an estimate for sales for lebrikizumab following the positive Phase 2b data readout in atopic dermatitis. Chen keeps an Overweight rating on Dermira shares.
News For DERM From the Last 2 Days
There are no results for your query DERM